Buffett InvestorsNZX
Back
OCA.NZ

Oceania Healthcare Trades at $0.72 — Its Assets Are Worth $1.57 Per Share

Buying $1.57 of Assets for $0.72

There are several ways to look for value in stocks. One of the most direct is to compare a company's share price against its net tangible assets (NTA) per share — essentially, what the underlying assets are worth per share after deducting debt and intangibles.

For Oceania Healthcare (NZX: OCA), a NZ aged care and retirement village operator, that comparison is striking. NTA per share stands at $1.57 NZD. The share price: $0.72 NZD. That's a 54% discount to asset value — investors are paying 46 cents in the dollar for the underlying property and business assets.

This kind of discount doesn't automatically mean the stock is a buy. Sometimes it exists for good reasons. But it's worth understanding what's driving it, and whether the gap is as wide as it should be.

The Business at a Glance

Oceania Healthcare operates 44 retirement village and aged care sites across New Zealand, serving more than 3,600 residents. The business runs two interconnected models:

  • •Aged care facilities: Providing rest home, hospital-level, and dementia care under government funding contracts
  • •Retirement villages: Selling occupation right agreements (ORAs) to retirees who pay a significant upfront sum to live in village units, with Oceania retaining a deferred management fee upon departure

The retirement village model is capital-intensive — you build or buy the properties, then sell the right to live in them. The value accrues over time as residents move in, deferred fees accumulate, and property values rise.

Key Numbers

  • •Share price: $0.72 NZD
  • •52-week range: $0.715 – $0.745 (very tight — the stock has been range-bound)
  • •Market cap: ~$521M NZD
  • •NTA per share: $1.57 NZD (stock at 46% of NTA)
  • •P/E ratio: ~10x (trailing)
  • •EPS: $0.072 NZD
  • •Dividend yield: 0% (no dividends currently paid)
  • •Q2 FY2026 net income: $4.9M NZD (up 157.5% year-on-year)
  • •Occupancy: 94% at unaffected sites
  • •Analyst consensus target: $0.95–0.99 NZD (implied upside: ~35–38%)
  • •Analyst consensus: Buy (3 analysts, 0 sell recommendations)
  • •Next results: May 31, 2026

Why the Discount Exists

The NTA discount in aged care and retirement village stocks is common across the NZ sector — Ryman Healthcare and Summerset Group also trade below their NTA at various times. The discount reflects:

1. High gearing: Retirement village developers carry significant debt to fund construction and development. Higher interest rates over the past few years made that debt more expensive and reduced asset values

2. Unsold stock: Units that are built but not yet sold represent capital tied up earning nothing. Oceania has been working through a pipeline of development completions

3. Earnings complexity: The retirement village accounting model is notoriously difficult to follow — gains on resales, deferred management fees, and development profits all flow through differently under NZ accounting standards

4. No dividend: Oceania does not currently pay a dividend, removing the income investor support that companies like Summerset benefit from

What's Improving

The picture is getting better. Q2 FY2026 net income of $4.9M was up 157.5% year-on-year. Occupancy of 94% is strong and indicates the demand fundamentals are intact — there is no shortage of ageing New Zealanders needing care or retirement accommodation.

A significant positive is the appointment of Suzanne Dvorak as CEO. Leadership transitions can be genuinely re-rating events for companies that have underperformed under prior management, and the market will be watching her first full-year result (due May 31, 2026) closely.

Interest rate falls matter enormously for this sector. As the RBNZ continues its OCR cutting cycle, the cost of carrying development debt falls, asset valuations recover, and the discount to NTA typically narrows.

The Risks

  • •Balance sheet: High debt levels mean interest rate sensitivity cuts both ways — rates rising again would hurt more than most NZX companies
  • •Development execution: Retirement village operators that build too fast or in the wrong locations can create long-lasting oversupply problems
  • •No dividend: For income investors, there's no yield to compensate for holding while the discount closes
  • •Complexity: The accounting is opaque enough that it's genuinely difficult for retail investors to value the business with confidence
  • •Sector headwinds: Government funding for aged care beds remains a political battleground in NZ — any unfavourable policy changes affect margins

The Bottom Line

Oceania Healthcare at $0.72 against $1.57 NTA is one of the sharper discounts to asset value on the NZX. With a new CEO, improving occupancy, net income up 157%, analysts targeting $0.95–0.99, and the OCR cycle moving in the sector's favour, the ingredients for a discount-narrowing re-rating are present. The absence of a dividend and the balance sheet complexity are legitimate reasons for caution — but for investors who understand the retirement village model, this is a stock that deserves a closer look.

*Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice. Stock data may not be real-time. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.*